Applying a Lifespan Developmental Perspective to Chronic Pain: Pediatrics to Geriatrics - 31/08/16
, Elliot J. Krane ‡, §, Kenneth E. Schmader ¶, ‖, Debra K. Weiner ∗∗, ††Abstract |
An ideal taxonomy of chronic pain would be applicable to people of all ages. Developmental sciences focus on lifespan developmental approaches, and view the trajectory of processes in the life course from birth to death. In this article we provide a review of lifespan developmental models, describe normal developmental processes that affect pain processing, and identify deviations from those processes that lead to stable individual differences of clinical interest, specifically the development of chronic pain syndromes. The goals of this review were 1) to unify what are currently separate purviews of “pediatric pain,” “adult pain,” and “geriatric pain,” and 2) to generate models so that specific elements of the chronic pain taxonomy might include important developmental considerations.
Perspective |
A lifespan developmental model is applied to the forthcoming Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks—American Pain Society Pain Taxonomy to ascertain the degree to which general “adult” descriptions apply to pediatric and geriatric populations, or if age- or development-related considerations need to be invoked.
Le texte complet de cet article est disponible en PDF.Highlights |
• | An ideal taxonomy of chronic pain would be applicable to people of all ages. |
• | A lifespan developmental approach might unify pediatric, adult, and geriatric pain. |
• | Childhood is a period of rapid neural proliferation, integration, and plasticity. |
• | Homeostenosis restricts older persons' responses to pain and stress. |
• | Foci of a pain taxonomy should be individuals in pain, not pain in individuals. |
Key words : Pain, pediatrics, geriatrics, children, elderly, life-span development
Plan
| The views expressed in this article are those of the authors, none of whom has financial conflicts of interest relevant to the specific issues discussed. No official endorsement by the U.S. Food and Drug Administration (FDA) or the pharmaceutical and device companies that have provided unrestricted grants to support the activities of the ACTTION public-private partnership with the FDA should be inferred. Financial support for this supplement and for the development of the AAPT has been provided by the ACTTION public-private partnership, which has received research contracts, grants, or other revenue from the FDA, multiple pharmaceutical and device companies, and other sources. A complete list of current ACTTION sponsors is available at: partners. |
Vol 17 - N° 9S
P. T108-T117 - septembre 2016 Retour au numéro
Article précédent
- Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification
- William Maixner, Roger B. Fillingim, David A. Williams, Shad B. Smith, Gary D. Slade
- Approaches to Demonstrating the Reliability and Validity of Core Diagnostic Criteria for Chronic Pain
- Stephen Bruehl, Richard Ohrbach, Sonia Sharma, Eva Widerstrom-Noga, Robert H. Dworkin, Roger B. Fillingim, Dennis C. Turk
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?